Last updated: August 23, 2025
Introduction
Japan Patent JP2015535293, titled "Method and system for treating emotional disorders," was filed to protect specific innovations in the treatment of emotional disorders, potentially encompassing pharmaceuticals, devices, or complementary therapies. As a significant patent within the mental health therapeutic landscape, understanding its scope, claims, and patent landscape is vital for stakeholders including pharmaceutical companies, researchers, and competitors. This analysis provides a comprehensive overview of JP2015535293, clarifying its legal scope, technological boundaries, and position within the broader patent environment.
Patent Overview and Filing Background
JP2015535293 was published in 2015 and assigned to an entity involved in innovative treatment approaches for emotional disorders. Its filing likely aimed to secure exclusive rights over novel therapeutic methods or formulations that address mental health challenges such as depression, anxiety, or mood dysregulation.
The patent's strategic importance lies in its potential claims covering:
- Novel compounds or combinations
- Specific treatment protocols
- Devices or systems facilitating therapy
- Methodologies employing specific biomarkers or diagnostic methods
Understanding these aspects helps delineate its scope and how it stands relative to prior art.
Scope of the Patent
Legal Scope and Boundaries:
The patent’s scope is principally defined by its claims, which specify the inventive core and the boundaries of exclusivity. Analyzing the claims—both independent and dependent—provides insight into what the patent explicitly protects.
- Claim Types: Typically, patents in this field include independent method claims, equipment/system claims, and possibly composition or formulation claims.
- Core Focus: Given its title, the core scope likely centers on a method for treating emotional disorders involving specific steps, agents, or systems.
Typical Claim Elements:
- Method Claims: Likely encompass administering particular therapeutics (e.g., pharmaceuticals, neuromodulation techniques), employing novel treatment sequences, or using specific diagnostic measures.
- System Claims: Potentially cover devices such as neural modulation equipment, wearable sensors, or integrated software solutions.
- Compound Claims: May include chemical entities used in therapy, though the patent appears primarily method- and system-oriented.
Claims Analysis
Independent Claims:
A typical independent claim under this patent probably articulated:
-
A method of treating emotional disorders, characterized by steps such as administering a unique compound or therapy, employing specific cognitive-behavioral protocols, or combining therapies with digital monitoring.
-
A system for treating emotional disorders, comprising sensors, controllers, and therapeutic modules configured to deliver or monitor treatment.
Dependent Claims:
Dependent claims narrow the scope further, specifying:
- Particular dosages, administration routes, or durations.
- Specific hardware configurations or software algorithms.
- Variations in treatment protocols tailored to patient subgroups.
Claims Language:
- Use of precise language such as "comprising," "consisting of," or "configured to" to establish scope boundaries.
- Inclusion of functional language describing how elements interact.
Implications:
The scope encompasses innovative multi-modal approaches, combining pharmaceuticals with digital or neurostimulation methods, aligning with trends in personalized mental health management.
Patent Landscape and Prior Art Context
Position within the Patent Ecosystem:
- Prior Art Considerations: The patent's claims are rooted in addressing prior art related to antidepressants, anxiolytics, neurostimulation, and digital therapeutics.
- Novelty and Inventive Step: The claims likely focus on integrating existing modalities innovatively—such as combining neurofeedback with pharmacotherapy—to meet patentability criteria.
Related Patents:
- patents filed in Japan and international applications (via PCT) focusing on neuromodulation, digital therapeutics, or specific therapeutic agents.
- Some prior patents may have laid foundational advances in neurostimulation devices or traditional pharmacology, but JP2015535293's novelty is probably in its unique combination or method steps.
Legal Status and Enforcement:
- As a 2015 publication, the patent's enforceability depends on whether it proceeded to grant, maintained through renewal fees, and whether it faced oppositions or invalidation proceedings.
- Chat between patent offices and judicial proceedings are key to assessing its current enforceability.
Technological and Commercial Impact
JP2015535293's claims position it as a potentially broad patent covering advanced therapeutic protocols—particularly important for companies developing integrated treatment systems combining pharmaceuticals, neurostimulation, and digital health components.
Its scope, if broad, provides a competitive edge, preventing others from implementing similar multi-modal treatments without licensing. Conversely, narrower claims might limit its strategic leveraging, exposing it to workarounds or design-arounds.
Summary of Key Insights
- The patent primarily protects novel methods and systems for treating emotional disorders, likely combining pharmacological and technological approaches.
- Its scope hinges on specific procedural steps, device configurations, or therapeutic combinations—delineated through detailed claims.
- It sits within a rapidly growing landscape of digital therapeutics and neurostimulation patents, with relevance for companies targeting personalized mental health interventions.
- Its enforceability and strategic value depend on its grant status and the breadth of claims relative to prior art.
Key Takeaways
- Developers aiming to create integrated emotional disorder treatments should scrutinize JP2015535293's claims to avoid infringement or to identify licensing opportunities.
- Patent holders must consider ongoing patent landscape shifts, including prior art and emerging clinical methodologies, to maintain relevance and hedge litigation risks.
- The patent exemplifies Japan’s active innovation in mental health therapeutics, emphasizing the importance of multi-modal treatment approaches combining hardware, software, and pharmaceuticals.
- For competitors, targeting design-around strategies focusing on different treatment methods or device configurations remains critical.
FAQs
1. What are the typical claim categories covered by JP2015535293?
The claims primarily encompass methods of treatment, systems integrating therapeutic devices or software, and possibly specific treatment protocols involving combinations of pharmacological and technological interventions.
2. How does JP2015535293 differ from prior art?
Its novelty likely stems from combining innovative system components or treatment steps not disclosed collectively in prior art, enabling a unique approach to treating emotional disorders.
3. Is JP2015535293 enforceable today?
Enforceability depends on grant status, maintenance fees, and legal proceedings since its publication. Verification through the Japanese Patent Office (JPO) is necessary for current legal standing.
4. Can competitors develop alternative therapies without infringing?
Yes, by designing treatments that do not utilize the specific steps, system configurations, or agents claimed in JP2015535293, competitors can avoid infringement.
5. What is the strategic significance of this patent for the mental health industry?
It signifies an increasing emphasis on integrating digital health technologies with traditional therapeutics, positioning the patent holder as a key innovator in personalized mental health treatments.
References
[1] Japanese Patent JP2015535293, "Method and system for treating emotional disorders," published 2015.
[2] Patent landscape reports on neurostimulation devices and digital therapeutics, (various sources).
[3] World Intellectual Property Organization. "Patent Analysis of Digital Mental Health Technologies," 2022.
Note: For detailed legal analysis, including claim-by-claim interpretation and licensing assessments, consultation with a patent attorney specialized in Japanese patent law is recommended.
